Merit Medical Systems Inc (MMSI)

Currency in USD
70.71
+0.17(+0.23%)
Closed·
70.730.00(0.00%)
·
Earnings results expected in 15 days
MMSI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
69.8871.30
52 wk Range
66.34100.19
Key Statistics
Prev. Close
70.54
Open
71.09
Day's Range
69.88-71.3
52 wk Range
66.34-100.19
Volume
320.95K
Average Vol. (3m)
736.54K
1-Year Change
-23.1079%
Book Value / Share
26.72
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MMSI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
100.55
Upside
+42.19%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Merit Medical Systems Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Merit Medical Systems Inc Earnings Call Summary for Q3/2025

  • Merit Medical Systems (MMSI) exceeded Q3 2025 forecasts with EPS of $0.92 (10.84% above expectations) and revenue of $384.2 million, driving a 2.09% after-hours stock increase to $81.39.
  • Revenue grew 13% year-over-year with strong performance in both U.S. (12% growth) and international markets (13% growth), despite challenges in China due to macroeconomic factors.
  • The company achieved record-high gross margin of 53.6% and increased free cash flow by 38% year-over-year to $53 million, demonstrating improved operational efficiency.
  • Management raised 2025 guidance, projecting 11-12% revenue growth, non-GAAP EPS of $3.66-$3.79, and minimum free cash flow of $175 million for the year.
  • Strategic initiatives including product launches and recent acquisitions are expected to drive future growth, though management acknowledged potential challenges from supply chain disruptions and regulatory changes.
Last Updated: 10/30/2025, 06:36 PM
Read Full Transcript
Merit investor slides for Q3/2025
Merit Medical Q3 2025 slides
Last Update: Oct 30, 2025
See full investor slides

Compare MMSI to Peers and Sector

Metrics to compare
MMSI
Peers
Sector
Relationship
P/E Ratio
32.6x24.7x−0.5x
PEG Ratio
6.620.880.00
Price / Book
2.6x2.2x2.6x
Price / LTM Sales
2.8x1.6x3.2x
Upside (Analyst Target)
43.2%37.6%47.6%
Fair Value Upside
Unlock19.9%6.1%Unlock

Analyst Ratings

9 Buy
2 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 100.55
(+42.19% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy92.00+30.11%104.00MaintainApr 15, 2026
BTIG
Buy100.00+41.42%107.00MaintainApr 13, 2026
Canaccord
Buy90.00+27.28%99.00MaintainApr 07, 2026
BTIG
Buy107.00+51.32%-MaintainApr 01, 2026
BTIG
Buy107.00+51.32%-MaintainMar 24, 2026

Earnings

Latest Release
Feb 24, 2026
EPS / Forecast
1.04 / 0.95
Revenue / Forecast
393.9M / 389.44M
EPS Revisions
Last 90 days

MMSI Income Statement

People Also Watch

57.07
MTDR
-0.45%
85.27
QLYS
+2.46%
475.76
CIEN
+1.83%
21.57
KEY
-0.28%
96.11
TROW
+0.28%

FAQ

What Is the Merit (MMSI) Stock Price Today?

The Merit stock price today is 70.71 USD.

What Stock Exchange Does Merit Trade On?

Merit is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Merit?

The stock symbol for Merit is "MMSI."

What Is the Merit Market Cap?

As of today, Merit market cap is 4.21B USD.

What Is Merit's Earnings Per Share (TTM)?

The Merit EPS (TTM) is 2.13.

When Is the Next Merit Earnings Date?

Merit will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is MMSI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Merit Stock Split?

Merit has split 6 times.

How Many Employees Does Merit Have?

Merit has 7500 employees.

What is the current trading status of Merit (MMSI)?

As of Apr 15, 2026, Merit (MMSI) is trading at a price of 70.71 USD, with a previous close of 70.54 USD. The stock has fluctuated within a day range of 69.88 USD to 71.30 USD, while its 52-week range spans from 66.34 USD to 100.19 USD.

What Is Merit (MMSI) Price Target According to Analysts?

The average 12-month price target for Merit is 100.55 USD, with a high estimate of 122 USD and a low estimate of 78 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +42.19% Upside potential.

What Is the MMSI Premarket Price?

MMSI's last pre-market stock price is 70.69 USD. The pre-market share volume is 80.00, and the stock has decreased by 0.15, or 0.21%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.